Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-14

Study Completion Date

2024-10-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since post hemorrhoidectomy pain is a severe and common post operative symptom so there is a need to find a suitable method for reducing this pain, up to our knowledge, this the first study in ZUH to compare between ketrolac, light Marcaine, corticosteroids and diclofenac sodium injection at surgical site for relieve of post operative pain. This is a randomized controlled comparative prospective clinical trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Topical Analgesia Post-Haemorrhoidectomy

NCT04276298

Hemorrhoid Pain Hemorrhoids

COMPLETED PHASE2/PHASE3

Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)

NCT06872151

Anus Diseases Gastrointestinal Diseases Intestinal Diseases +3 more

COMPLETED PHASE4

Study of Pain Control in Hemorrhoidectomy

NCT00890721

Hemorrhoid

COMPLETED PHASE3

Effectiveness of Metronidazole in Pain Control Posthemorrhoidectomy

NCT02328144

Hemorrhoids

COMPLETED PHASE3

Topical vs Oral Metronidazole After Benign Anorectal Surgery

NCT05038605

Hemorrhoids Anal Fissure Anal Fistula

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Post Operative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A: ketorolac and light marcaine injection

Group Type EXPERIMENTAL

ketorolac and light marcaine

Intervention Type DRUG

local injection at surgical site of 30 mg ketorolac and 7-1.5 mg\\kg\\dose light marcaine

group B: light marcaine injection

Group Type EXPERIMENTAL

light marcaine

Intervention Type DRUG

local injection at surgical site of 7-1.5 mg\\kg\\dose light marcaine

group C: corticosteroids injection

Group Type EXPERIMENTAL

Corticosteroids injection

Intervention Type DRUG

local injection at surgical site of 40 mg\\ dose of dexamethasone

group D: topical diclofenac sodium

Group Type EXPERIMENTAL

Diclofenac Sodium Gel

Intervention Type DRUG

topical application of Diclofenac Sodium Gel

control group

control group was given the ordinary analgesic protocol without local analgesic application

Group Type SHAM_COMPARATOR

the standard analgesic protocol

Intervention Type OTHER

the routine analgesia was given without local analgesia application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ketorolac and light marcaine

local injection at surgical site of 30 mg ketorolac and 7-1.5 mg\\kg\\dose light marcaine

Intervention Type DRUG

light marcaine

local injection at surgical site of 7-1.5 mg\\kg\\dose light marcaine

Intervention Type DRUG

Corticosteroids injection

local injection at surgical site of 40 mg\\ dose of dexamethasone

Intervention Type DRUG

Diclofenac Sodium Gel

topical application of Diclofenac Sodium Gel

Intervention Type DRUG

the standard analgesic protocol

the routine analgesia was given without local analgesia application

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* both sex.
* age from 18 to 60.

Exclusion Criteria

* patient refusal.
* patients with associated ano-rectal diseases such as fissures, fistulas, ano-proctitis, recurrent or thrombosed hemorrhoids and ano-rectal malignancy.
* patients with liver cell failure. patients unfit for surgery according to American Society of Anesthesiologists.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No